Kingdom), 4.4% NaHCO 3 (pH 8.1), 20 mM HEPES (pH 8.0), 0.5% glucose, 8-g/ml garamycin, 1-g/ml amphotericin B (Fungizone), 25-g/ml vancocin, and 1-g/ml cycloheximide. On culture days 3, 4, and 5 the culture plate was centrifuged (2,500 ϫ g for 1 h); on culture day 3, the culture medium was exchanged. Cultured C. pneumoniae organisms were stained with the Phadebact Chlamydia culture confirmation test (Boule Diagnostics AB, Huddinge, Sweden) and counted with a fluorescent microscope at a magnification of ϫ400. DNA of cultured C. pneumoniae was extracted with the QIAamp DNA Mini kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer's instructions.
PCR. Real-time PCR was performed with the ABI Prism 7700 sequence detector system (Applied Biosystems, Foster City, Calif.). The gene coding for the major outer membrane protein (MOMP) was used as the target for amplification. DNA of cultured C. pneumoniae was used as the standard in dilutions between 1 copy and 6 ϫ 10 4 copies. A pT7Blue-3 vector (Novagen, Madison, Wis.) with an inserted T45 MOMP gene (1,100 bp) of known concentration was compared to the standard with agreement. Either 5 or 10 l of extracted DNA was analyzed with the PCR mixture in a total volume of 25 l. The PCR mixture consisted of 10 mM Tris (pH 8. The real-time PCR run was 2 min at 50°C, 10 min at 95°C, and 40 repeats of 15 s at 95°C and 1 min at 60°C. Nested touchdown PCR was performed with primers from the MOMP genes of C. pneumoniae and C. psittaci as described previously (4, 10) . Five microliters of extracted DNA was analyzed in a total volume of 50 l.
Twenty-three of 105 respiratory samples were positive by real-time PCR (Table 1 ). All samples were analyzed in triplicate, and samples with positive or indistinct results were reanalyzed at least once. A sample was considered positive if three of three assay results were positive in the triplicate test and if the average value for the PCR run was greater than or equal to 1.0.
C. pneumoniae DNA copies varied from 6.0 ϫ 10 2 to 6.7 ϫ 10 6 per ml of the acetylcysteine-treated samples. The majority of all samples (70%) had copy numbers below 1 ϫ 10 4 per ml, but the greater part of the sputum samples contained large amounts of C. pneumoniae DNA, with an average of 8.6 ϫ 10 5 copies per ml. A parallel study with real-time PCR and nested touchdown PCR was performed with acetylcysteine-treated samples. Sixty-two samples, from where there was material left from previous sampling, were prepared and run directly on real-time PCR and nested PCR assays. Five microliters of extracted DNA was used with both methods. The real-time PCR method revealed a higher number of positive samples than nested PCR and showed no inhibitor tendency ( Table 2) . Sixteen of 23 real-time PCR-positive samples were confirmed by nested PCR and ranged between 6.0 ϫ 10 2 and 2.5 ϫ 10 6 copies per ml. The seven unconfirmed positive samples had all copy numbers below 4.4 ϫ 10 3 per ml. With nested PCR as the "gold standard," real-time PCR had a sensitivity of 80% (16 of 20 samples) and a specificity of 83% (35 of 42 samples). The positive predictive value was 70% (16 of 23 samples) and the negative predictive value was 90% (35 of 39 samples). For both studies, patient samples had a mean coefficient of variation value of 26% in the triplicate assays. A titration of full-length bacterial DNA with plasmid DNA, both corresponding to 0.5 to 50,000 copies, was also analyzed by real-time PCR and nested PCR in parallel. The detection limit was around one to five copies for both methods, independent of template DNA origin. The real-time PCR system was tested against different strains of C. pneumoniae, C. trachomatis, and C. psittaci; only the C. pneumoniae strains were amplified. A theoretical comparison with all GenBank, EMBL, and DDBJ sequences was also performed.
The conventional methods that are used to detect respiratory C. pneumoniae infections all have limitations, and there is a need for new, automated, and better-validated diagnostic methods. Recently, real-time PCR has been used as a quantitative gene amplification technique for the detection of both bacteria and viruses associated with respiratory tract diseases (3, 5, 11) . In this study, real-time PCR detected C. pneumoniae DNA of a wide quantitative range. Twenty-three of 105 analyzed samples were real-time PCR positive and originated from 13 patients, all with positive results from sputum specimens. The sputum specimens, with an average of 8.6 ϫ 10 5 copies per ml, had large amounts of C. pneumoniae DNA in comparison to nasopharyngeal and throat specimens. This can be explained by a higher number of cells and larger sampling volume for sputum than for the other two sampling types. This result could also be due to a higher rate of bacterial secretion in sputum. Sputum sampling is easy but limited, since a C. pneumoniae infection does not always generate sputum production. Therefore, we conclude that sputum samples should be collected when possible from patients with a suspected respiratory C. pneumoniae infection. The sensitivity of realtime PCR was investigated by a parallel comparison with nested touchdown PCR. Nested PCR has previously been validated as a sensitive and specific detection method for C. pneumoniae when compared to other methods such as cell culture (1, 10) . Sixteen of 20 samples positive by nested PCR were confirmed by real-time PCR. An additional seven samples were detected as positives by real-time PCR; five of these samples originated from four patients previously not diagnosed as having a C. pneumoniae infection. It is possible that realtime PCR is a more sensitive detection method than nested PCR when samples from patients are used. There are several advantages of real-time PCR as a diagnostic method, including rapidity, automation, quantitative measurement, and minimized risk for carryover contamination. Nested touchdown PCR has shown high sensitivity for C. pneumoniae detection, but it is labor-intensive and has no capacity for quantitative measurement. We conclude that real-time PCR is a promising future diagnostic method for the quantitative detection of respiratory, and perhaps other, C. pneumoniae infections. 
